| Authors: |
Berry-Kravis E; Departments of Pediatrics and Neurological Sciences, Rush University Medical Center, Chicago, IL, USA., Hagerman R; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis Medical Center, Sacramento, CA, USA.; Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA, USA., Cohen J; Fragile X Alliance Inc, North Caulfield, Melbourne, VIC, Australia.; Honorary Research Associate, Diagnosis and Development, Victorian Clinical Genetic Services and Murdoch Childrens Research Institute, Melbourne, VIC, Australia., Budimirovic D; Departments of Psychiatry and Child Psychiatry, Fragile X Clinic, Kennedy Krieger Institute/the Johns Hopkins Medical Institutions, Baltimore, MD, USA.; Department of Psychiatry & Behavioral Sciences-Child Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, USA., Buchanan CB; Greenwood Genetic Center, Greenville, SC, USA., Silove N; The Children's Hospital at Westmead, Sydney, Australia., Tich N; Harmony Biosciences, Plymouth Meeting, PA, USA., Thibodeau A; Harmony Biosciences, Plymouth Meeting, PA, USA., Dobbins T; The Griesser Group, Conshohocken, PA, USA., Sebree T; Pharmaceutical Consulting, LLC, Johnson City, TX, USA., O'Quinn S; Perissos Inc, Wake Forest, NC, USA., Albers DS; Harmony Biosciences, Plymouth Meeting, PA, USA., Bzdek KG; Harmony Biosciences, Plymouth Meeting, PA, USA. Publications@harmonybiosciences.com., Nomikos G; Harmony Biosciences, Plymouth Meeting, PA, USA., Budur K; Harmony Biosciences, Plymouth Meeting, PA, USA. |
